Weiss Multi-Strategy Advisers’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-391,633
| Closed | -$71.9M | – | 828 |
|
|
2021
Q2 | $71.9M | Buy |
391,633
+165,882
| +73% | +$30.5M | 1.58% | 2 |
|
|
2021
Q1 | $34.5M | Buy |
225,751
+87,084
| +63% | +$13.3M | 0.76% | 11 |
|
|
2020
Q4 | $21.7M | Buy |
138,667
+129,149
| +1,357% | +$20.2M | 0.42% | 57 |
|
|
2020
Q3 | $1.09M | Sell |
9,518
-2,508
| -21% | -$287K | 0.03% | 403 |
|
|
2020
Q2 | $1.35M | Buy |
12,026
+2,159
| +22% | +$242K | 0.04% | 360 |
|
|
2020
Q1 | $886K | Buy |
9,867
+4,579
| +87% | +$411K | 0.03% | 300 |
|
|
2019
Q4 | $572K | Buy |
5,288
+288
| +6% | +$31.2K | 0.01% | 457 |
|
|
2019
Q3 | $490K | Hold |
5,000
| – | – | 0.01% | 391 |
|
|
2019
Q2 | $655K | Buy |
5,000
+3,000
| +150% | +$393K | 0.02% | 332 |
|
|
2019
Q1 | $270K | Sell |
2,000
-3,000
| -60% | -$405K | 0.01% | 393 |
|
|
2018
Q4 | $487K | Buy |
+5,000
| New | +$487K | 0.02% | 294 |
|
|
2015
Q4 | – | Sell |
-5,083
| Closed | -$795K | – | 432 |
|
|
2015
Q3 | $795K | Buy |
+5,083
| New | +$795K | 0.04% | 239 |
|
|
2015
Q1 | – | Sell |
-5,000
| Closed | -$925K | – | 514 |
|
|
2014
Q4 | $925K | Hold |
5,000
| – | – | 0.03% | 264 |
|
|
2014
Q3 | $829K | Sell |
5,000
-380
| -7% | -$63K | 0.02% | 346 |
|
|
2014
Q2 | $841K | Buy |
5,380
+1,850
| +52% | +$289K | 0.02% | 382 |
|
|
2014
Q1 | $537K | Sell |
3,530
-2,690
| -43% | -$409K | 0.01% | 577 |
|
|
2013
Q4 | $827K | Buy |
6,220
+3,780
| +155% | +$503K | 0.02% | 436 |
|
|
2013
Q3 | $283K | Buy |
+2,440
| New | +$283K | 0.01% | 600 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 702 |
|